Actively Recruiting
Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders
Led by Genesis Athens Clinic · Updated on 2024-12-27
100
Participants Needed
1
Research Sites
366 weeks
Total Duration
On this page
Sponsors
G
Genesis Athens Clinic
Lead Sponsor
N
National and Kapodistrian University of Athens
Collaborating Sponsor
AI-Summary
What this Trial Is About
Autologous platelet rich plasma (PRP) intraovarian infusion may improve ovarian response to controlled ovarian stimulation as well as the hormonal profile of poor ovarian response infertile women subjected to intracytoplasmic sperm injection (ICSI) treatment.
CONDITIONS
Official Title
Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Poor Ovarian Response according to Bologna Criteria, fulfilling at least 2 of the following: Age 40 years or older
- Anti-Müllerian Hormone (AMH) less than 1.1 ng/ml OR antral follicle count (AFC) less than 7
- Three or fewer oocytes retrieved with a conventional stimulation protocol
- Discontinuation of any complementary or adjuvant treatments, including hormone replacement and acupuncture, for at least three months prior to recruitment
- Willingness to comply with all study requirements
You will not qualify if you...
- Any pathological disorder affecting reproductive system anatomy
- Irregular menstrual cycles
- Amenorrhea
- Endometriosis
- Adenomyosis
- Fibroids or adhesions in the reproductive system
- Infections in the reproductive system
- Current or previous diagnosis of cancer related to the reproductive system
- Family history of reproductive system cancer
- Severe male factor infertility
- Prior referral for Preimplantation Genetic Testing (PGT)
- Ovarian inaccessibility
- Endocrinological disorders including hypothalamus-pituitary disorders, thyroid dysfunction, diabetes mellitus, or metabolic syndrome
- Body Mass Index (BMI) over 30 kg/m2 or under 18.5 kg/m2
- Systemic autoimmune disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Genesis Athens Clinic
Athens, Attica, Greece, 15232
Actively Recruiting
Research Team
A
Agni Pantou, M.D
CONTACT
K
Konstantinos Pantos, M.D., Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here